Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Diabetes injection more effective than orlistat for weight loss

  • Comment

Medical trials have revealed a diabetes injection, tested at 19 different hospitals, appears to help weight loss more than leading anti-obesity druh orlistat.

The Lancet study found the injection curbed patient’s hunger and had better weight loss results than the leading obesity drug orlistat. Liraglutide contains a satiety hormone and helps lower risk factors for diabetes.

When patients took the drug their chances of shedding notable amounts of weight doubled compared to those on orlistat.

But despite the results there were a number of drawbacks to the treatment. Firstly the drug is costly at £500 for six months of treatment and it has to be injected daily.

The longer-term risks of the drug are yet to be tested as the trial only ran for 20 weeks with just 564 participants.

During the trial three groups of patients were asked to exercise and reduce their diet by 500 calories a day. The first set was given a placebo, the second orlistat and the third liraglutide.

During the trial over three quarters of those on 3mg of liraglutide lost more than 50% weight, compared with 44% with 120mg of orlistat and 30% with a placebo.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs